ArticleNature communications2025
Size-inverse molecular sieving xenon/krypton separation through cation-tuned gating effect within Linde Type A zeolites.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficient screening for enhanced Xe/Kr separationRSC advances · 2026Article
- Heteroatom Engineering in Robust Al-Based MOFs for Efficient Separation of Xenon over Krypton.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achieving highly selective xenon/krypton separation is a longstanding challenge due to the similar physicochemical properties of these noble gases. Here, we develop the cation-tuned gating sieving mechanism in Linde Type A zeolites to achieve a high xenon/krypton IAST selectivity over 1600. Through the cation exchange by Ag
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.